We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.675 | 4.36 | 4.99 | - | 38,838 | 08:00:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/4/2020 16:58 | Thanks Makendon, interesting comment from the spin off CEO: “We need a ‘Big Pharma’ partner to help us scale up our activities,” he said. I think PIs who are selling thinking we are at the end of the news flow cycle for a while will be in for a shock. I suspect it I just about to start | talk2dubya | |
01/4/2020 16:40 | I think the following is worth watching and in depth analysis of Covid-19. It’s about 40 mins long but lots of detail: | makendon | |
01/4/2020 16:35 | As Covid-19 started to gather steam in China, Synairgen tried to get things started, but to no avail. Italy was the next plan. “We had some really good interaction there,” said Marsden. “But they went from, you know, just busy to very busy to extremely busy to unable-to-communicat Eventually, they decided their home ground — the UK, where they have an ongoing COPD trial — would be the best place to kick off a Covid-19 study. Initially, the pilot phase of the trial will have 100 patients (50 will get a placebo, and 50 will get SNG001). If all goes well, a pivotal study will be conducted. | makendon | |
01/4/2020 16:34 | I dont think it is the WHO trial toff but it is interferon. | tidy 2 | |
01/4/2020 16:25 | I think you will find that FARN is in the WHO trial | toffeeman | |
01/4/2020 16:15 | just thinking - perhaps the reason he avoided the WHO question is because they may currently be in discussions about its inclusion.... | hms_trader | |
01/4/2020 15:18 | and i would assume "later in the year" means quite soon as there is an immediate urgency to save as many lives as possible around the world. | asif12 | |
01/4/2020 15:03 | I guess this bit from the CEO, Richard Marsden: " Now we are talking about to scale up to hundreds of thousands and millions of doses later this year." Would correlate with the £ Billions opportunity for SNG described by Finncap and their comparisons to £3 Billion Avigan and $11 Billion Gilead. :o) | jev1 | |
01/4/2020 14:59 | Although you expect them to plan ahead for production it is always nice to hear it confirmed. Thanks for posting the interview and the youtube link. | pdt | |
01/4/2020 14:53 | Finncap driving this upwards as they are aggressively on the bid and bidding up for stock. Hmmm interesting.... | nobbygnome | |
01/4/2020 14:44 | Sounds like a banker Jev | tidy 2 | |
01/4/2020 14:43 | Yes the last part about already having the partner / infrastructure in place to scale up production to millions of doses later this year is brilliant. | 74tom | |
01/4/2020 14:41 | Love this part at the end: _____ " Now we are talking about to scale up to hundreds of thousands and millions of doses later this year." | jev1 | |
01/4/2020 14:32 | Great BBC at last!! | hazl | |
01/4/2020 14:23 | WHY NO TICK UPS for Likya123 on the other thread ??? Shamefull:(( Didn't see yours Nobby:( | bmnsa | |
01/4/2020 13:53 | Never write anyone off too soon (likya123) | bmnsa | |
01/4/2020 13:52 | Yes must admit there was no need to avoid the WHO question. Shame as it may detract from what otherwise was a good interview. | rafboy | |
01/4/2020 13:51 | Wow great interview MS side looks successful too there will be a massive world wide demand for interferon 1b now & in the future | bobaxe1 | |
01/4/2020 13:39 | Tidy2 I liked the article other than he repeat himself and evaded the question when he was asked about WHO. Otherwise ok (to someone not in the medical profession). | makendon | |
01/4/2020 13:36 | Good interview | tidy 2 | |
01/4/2020 13:31 | Nobby, great find, I have posted a YouTube link below to the specific section from the report | makendon |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions